Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-25-000425
Filing Date
2025-01-07
Accepted
2025-01-07 16:01:28
Documents
2
Period of Report
2025-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1413
2 EXHIBIT 24 ef20041166_ex24.htm EX-24 7825
  Complete submission text file 0001140361-25-000425.txt   10857
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Issuer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12770 HIGH BLUFF DRIVE SUITE 150 SAN DIEGO CA 92130
Business Address
Zhang Ping (Reporting) CIK: 0002050176 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 25514819